TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 392 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,718,000 | -3.4% | 288,057 | -0.8% | 0.03% | 0.0% |
| Q2 2021 | $4,886,000 | -7.8% | 290,307 | 0.0% | 0.03% | -13.9% |
| Q1 2021 | $5,301,000 | +0.6% | 290,307 | +0.2% | 0.04% | -5.3% |
| Q4 2020 | $5,272,000 | -15.7% | 289,657 | -17.3% | 0.04% | -22.4% |
| Q3 2020 | $6,251,000 | -0.5% | 350,412 | 0.0% | 0.05% | -3.9% |
| Q2 2020 | $6,283,000 | +18.1% | 350,412 | 0.0% | 0.05% | +8.5% |
| Q1 2020 | $5,319,000 | -23.0% | 350,412 | +0.1% | 0.05% | +4.4% |
| Q4 2019 | $6,910,000 | +15.1% | 350,212 | +0.3% | 0.04% | +12.5% |
| Q3 2019 | $6,005,000 | -2.7% | 349,112 | +0.1% | 0.04% | 0.0% |
| Q2 2019 | $6,172,000 | -12.8% | 348,712 | +0.4% | 0.04% | -9.1% |
| Q1 2019 | $7,075,000 | – | 347,312 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |